Georgia: Governor Signs Law Licensing Low-THC Oil Production

Generic 18 April 2019 | 0 Comments

Republican Gov. Brian Kemp signed legislation into law today to facilitate regulations governing the licensed production and distribution of oils and other products containing limited amounts of plant-derived THC. House Bill 324 (aka Georgia’s Hope Act) establishes a regulatory commission to oversee the eventual “production, manufacturing, and dispensing” of products possessing specified quantities of plant-derived […]

Tagged in , , ,

Study: Marijuana Provided For FDA-Approved Clinical Research Genetically Similar to Hemp

Generic 16 April 2019 | 0 Comments

Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado. Since 1968, the University of Mississippi farm, which is governed by the US National Institute on Drug Abuse, has […]

Tagged in , , ,

New York City: Lawmakers Advance Bills Limiting Drug Testing for Cannabis as a Condition of Employment, Probation

Generic 11 April 2019 | 0 Comments

Members of the New York City Council approved a pair of municipal bills this week limiting situations where those seeking employment or on probation may be drug tested for the past use of cannabis. Council members overwhelmingly voted in favor of a municipal proposal (No.1445) barring employers from drug testing certain job applicants for the […]

Tagged in ,

Georgia: Lawmakers Advance Bill To Regulate Low-THC Oil Production

Generic 6 April 2019 | 0 Comments

House and Senate lawmakers have approved legislation, House Bill 324, to regulate the production and dispensing of low-THC oil extracts to qualified patients. Republican Gov. Brian Kemp has stated that he intends to sign the bill into law. The measure amends existing law to provide for the licensed in-state “production, manufacturing, and dispensing” of products […]

Tagged in , , ,

NORML Responds To Latest Cannabis and Psychosis Claims

Generic 21 March 2019 | 0 Comments

A widely reported study appearing today in the British journal The Lancet alleges that an estimated 30 to 50 percent of psychosis cases in Europe are due to cannabis exposure, and that exposure to elevated levels of THC increases this risk. NORML has previously written on the data showing a multi-directional association between cannabis and […]

Tagged in , ,